Autoregulatory mechanism of enzyme activity by the nuclear localization signal of lysine-specific demethylase 1

被引:1
|
作者
Senanayaka, Dulmi [1 ]
Zeng, Danyun [1 ,4 ]
Alishiri, Sahar [1 ]
Martin, William J. [2 ,3 ]
Moore, Khadijah I. [1 ]
Patel, Roshni [1 ]
Luka, Zigmund [3 ]
Hirschi, Alexander [2 ,3 ]
Reiter, Nicholas J. [1 ]
机构
[1] Marquette Univ, Dept Chem, Milwaukee, WI 53233 USA
[2] Ctr Struct Biol, Nashville, TN USA
[3] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN USA
[4] Chinese Acad Sci, Wuhan Inst Phys & Math, Innovat Acad Precis Measurement Sci & Technol, Wuhan 430071, Peoples R China
关键词
HISTONE DEMETHYLATION; STRUCTURE PREDICTION; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; LARGER PROTEINS; RESONANCE ASSIGNMENTS; LSD1; DEMETHYLASE; TORSION ANGLES; NMR;
D O I
10.1016/j.jbc.2024.107607
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The N-terminal region of the human lysine-specific demethylase 1 (LSD1) has no predicted structural elements, contains a nuclear localization signal (NLS), undergoes multiple posttranslational modifications (PTMs), and acts as a proteinprotein interaction hub. This intrinsically disordered region (IDR) extends from core LSD1 structure, resides atop the catalytic active site, and is known to be dispensable for catalysis. Here, we show differential nucleosome binding between the full-length and an N terminus deleted LSD1 and identify that a conserved NLS and PTM containing element of the N terminus contains an alpha helical structure, and that this conserved element impacts demethylation. Enzyme assays reveal that LSD1's own electropositive NLS amino acids 107 to 120 inhibit demethylation activity on a model histone 3 lysine 4 dimethyl (H3K4me2) peptide (Kiapp ti 3.3 mM) and histone 3 lysine 4 dimethyl nucleosome substrates (IC50 ti 30.4 mM), likely mimicking the histone H3 tail. Further, when the identical, inhibitory NLS region contains phosphomimetic modifications, inhibition is partially relieved. Based upon these results and biophysical data, a regulatory mechanism for the LSD1catalyzed demethylation reaction is proposed whereby NLS-mediated autoinhibition can occur through electrostatic interactions, and be partially relieved through phosphorylation that occurs proximal to the NLS. Taken together, the results highlight a dynamic and synergistic role for PTMs, intrinsically disordered regions, and structured regions near LSD1 active site and introduces the notion that phosphorylated mediated NLS regions can function to fine-tune chromatin modifying enzyme activity.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Lysine-specific demethylase 7A (KDM7A): A potential target for disease therapy
    Li, Chang-Yun
    Liu, Yan-Jun
    Tao, Fan
    Chen, Ru-Yi
    Shi, Jin-Jin
    Lu, Jian-Fei
    Yang, Guan -Jun
    Chen, Jiong
    BIOCHEMICAL PHARMACOLOGY, 2023, 216
  • [32] The emerging roles of lysine-specific demethylase 4A in cancer: Implications in tumorigenesis and therapeutic opportunities
    Yang, Guanjun
    Li, Changyun
    Tao, Fan
    Liu, Yanjun
    Zhu, Minghui
    Du, Yu
    Fei, Chenjie
    She, Qiusheng
    Chen, Jiong
    GENES & DISEASES, 2024, 11 (02) : 645 - 663
  • [33] E239K mutation abolishes the suppressive effects of lysine-specific demethylase 1 on migration and invasion of MCF7 cells
    Zhang, Yu
    Wu, Tong
    Zhao, Bo
    Liu, Ziyu
    Qian, Rui
    Zhang, Jing
    Shi, Yueru
    Wan, Youzhong
    Li, Zhe
    Hu, Xin
    CANCER SCIENCE, 2022, 113 (02) : 489 - 499
  • [34] The role of lysine-specific demethylase 6A (KDM6A) in tumorigenesis and its therapeutic potentials in cancer therapy
    Chen, Li-Juan
    Xu, Xin-Yang
    Zhong, Xiao-Dan
    Liu, Yan-Jun
    Zhu, Ming-Hui
    Tao, Fan
    Li, Chang-Yun
    She, Qiu-Sheng
    Yang, Guan-Jun
    Chen, Jiong
    BIOORGANIC CHEMISTRY, 2023, 133
  • [35] Lysine specific demethylase 1 is a molecular driver and therapeutic target in sarcoma
    Dreher, Rachel D.
    Theisen, Emily R.
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [36] Development and crystallographic evaluation of histone H3 peptide with N-terminal serine substitution as a potent inhibitor of lysine-specific demethylase 1
    Amano, Yuichi
    Kikuchi, Masaki
    Sato, Shin
    Yokoyama, Shigeyuki
    Umehara, Takashi
    Umezawa, Naoki
    Higuchi, Tsunehiko
    BIOORGANIC & MEDICINAL CHEMISTRY, 2017, 25 (09) : 2617 - 2624
  • [37] Lysine-specific demethylase 2A expression is associated with cell growth and cyclin D1 expression in colorectal adenocarcinoma
    Cao, Lin-Lin
    Du, Changzheng
    Liu, Hangqi
    Pei, Lin
    Qin, Li
    Jia, Mei
    Wang, Hui
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2018, 33 (04) : 407 - 414
  • [38] The progenitor state is maintained by lysine-specific demethylase 1-mediated epigenetic plasticity during Drosophila follicle cell development
    Lee, Ming-Chia
    Spradling, Allan C.
    GENES & DEVELOPMENT, 2014, 28 (24) : 2739 - 2749
  • [39] Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology
    Lim, Soyoung
    Janzer, Andreas
    Becker, Astrid
    Zimmer, Andreas
    Schuele, Roland
    Buettner, Reinhard
    Kirfel, Jutta
    CARCINOGENESIS, 2010, 31 (03) : 512 - 520
  • [40] Screening for lysine-specific demethylase-1 inhibitors using a label-free high-throughput mass spectrometry assay
    Plant, Matthew
    Dineen, Tom
    Cheng, Alan
    Long, Alexander M.
    Chen, Hao
    Morgenstern, Kurt A.
    ANALYTICAL BIOCHEMISTRY, 2011, 419 (02) : 217 - 227